The present invention relates to waxes useful for cosmetic applications having stable oil-in-water emulsion-forming properties and, in some embodiments, stable gel-in-water-forming properties. In some embodiments, the waxes exhibit self-emulsifying properties, and can be produced without the addition of any other substances to achieve the emulsion (e.g., co-emulsifiers, hydrophilic polymers, polar surfactants, rheological modifiers, gelling agents). The waxes generally comprise: (a) polyglyceryl fatty acid ester, (b) a glycerol fatty acid ester, and 9c) a fatty alcohol. In particular embodiments, the polyglyceryl fatty acid ester can be a polyglyceryl-2, -3, or -4 fatty acid ester, and the fatty chain lengths of (a)-(c) can range from C12 to C22. In more particular embodiments, the waxes can comprise polyglyceryl stearate, glyceryl stearate, and stearyl alcohol. Gels, oil-in-water emulsions, and other compositions produced from the waxes, as well as uses and methods relating thereto, are also disclosed.

Provided is a high-purity 1,3-butylene glycol product that is odorless and is unlikely to cause acid concentration increase over time in a state containing water. A 1,3-butylene glycol product, having, according to a gas chromatographic analysis performed under predetermined conditions, a peak area ratio of 100 ppm or lower appearing in a relative retention time ranging from 1.35 to 1.45, provided that the relative retention time for a peak of 1,3-butylene glycol is 1.0.

The present invention relates to a cosmetic composition, comprising: (a) at least one compound having a specific chemical structure with two or more fatty amide groups; (b) at least one monosacharide. The cosmetic composition according to the present invention can have superior skin hydration effects because the hydration effect of each of the components (a) and (b) is synergistically enhanced by the combination of the components (a) and (b).

The invention relates generally to new compounds of formula (I), wherein R.sub.1, R′.sub.1, R.sub.2, R′.sub.2, R.sub.3, R′.sub.3, R.sub.4 R′.sub.4, R.sub.5, R′.sub.5, R.sub.6, R.sub.7 are independently of one another and denote hydrogen, hydroxyl, C.sub.1 to C.sub.6-alkyl group or R.sub.6 and R.sub.7 form together a C5-C6 ring system, and wherein n=0, 1, 2, 3, or 4. Moreover, the invention relates to the use of one or more compounds of formula (I) in cosmetic or pharmaceutical compositions, which are preferably dermatological compositions and are preferably used topically. ##STR00001##

The present invention provides a skin cosmetic containing the following components (A), (B), (C), (D), (E), and (F): (A) 0.5 to 7 mass % of a linear saturated fatty acid having 12 to 22 of carbon atom, (B) 0.01 to 5 mass % of an organic base, (C) 0.01 to 1 mass % of an inorganic base, (D) 0.6 to 7 mass % of a linear saturated alcohol having 12 to 22 of carbon atom, (E) 0.1 to 20 mass % of an oil agent, and (F) water, wherein
the total amount of the components (A) and (D) is (A)+(D)=from 1 to 14 mass %, the mass ratio of the component (A) to the total amount of the components (A) and (D) [(A)+(D)] is (A)/[(A)+(D)]=from 0.1 to 0.9, the molar ratio of the component (B) to the total amount of the components (B) and (C) [(B)+(C)] is (B)/[(B)+(C)]=from 5 to 50 mol %, and the molar ratio of the total amount of the components (B) and (C) [(B)+(C)] to the component (A) is [(B)+(C)]/(A)=more than 80 mol % and 120 mol % or less.

A method of treating atopic dermatitis and/or psoriasis comprising the application of select dilinoleate isohexides to the skin.

Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is a process for the care of keratinous material(s), comprising the application or administration of HS8, or a composition comprising thereof, to keratinous material(s). The composition may be used to improve the condition of skin, such as smoothing the skin, restoring skin elasticity and firmness, or decreasing or preventing wrinkles, and may be formulated for topical or transdermal administration.

A cosmetic composition is disclosed for applying to skin. The composition includes a liquid and dispersed in the liquid: any amount or form of fucoidan, any amount or form of beta glucan; and any amount of a marine extract. When the cosmetic composition is applied to the skin, the appearance of the skin is improved.

The present disclosure relates to compositions containing natural plant extracts that inhibit Hyaluronidase 1 and their use in effectively treating conditions such as dryness of skin and lips, skin damage due to UV radiation, chronic inflammatory conditions affecting the skin, the urinary bladder or prostate, osteoarthritis and joint pain, and also promoting wound healing.

The present disclosure describes a novel anhydrous topical pharmaceutical composition comprised of marine oil, such as fish oil or algae oil; vegetable oil having a an omega3 fat content greater than 9 wt %, such as hempseed oil, canola oil, flax seed oil, or cannabidiol; monolaurin, cetyl esters or wax; and medium chain triglycerides (“MCT”), and optionally fish collagen. The composition is useful for treating wounds, burns and skin conditions.